Omkar Pharmachem Other Announcement
Omkar Pharmachem Ltd filed its quarterly shareholding pattern for the period ending June 30, 2026. The filing includes a request regarding missing PAN details for some shareholders.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Omkar Pharmachem Ltd filed its quarterly shareholding pattern for the period ending June 30, 2026. The filing includes a request regarding missing PAN details for some shareholders.
Omkar Pharmachem submitted its Annual Secretarial Compliance Report for the year ended March 31, 2026. The report confirms overall regulatory compliance with no major deviations recorded.
Omkar Pharmachem announced a minor name spelling change for Managing Director Bhawani S Goyal. His designation and responsibilities remain unchanged, representing a purely administrative update.